Frequently Asked Questions

Nominations may be submitted online. To begin a nomination, click here.
You will be redirected to our nomination portal, Proposal Central, where you will be asked to register with your name and email address, as well as create a password.
 

Nomination requirements for the Merkin Prize are:

• Contact information for nominator
• Nominees’ names and organizations
• 50-word citation that names the technology and indicates its significance
• 150-word summary that explains why the technology meets the criteria for the Merkin Prize
• A statement of up to 1000 words that describes in detail the development of the nominated technology and its impact on human health
• A statement of up to 1000 words that describes in detail the substantive & quantifiable contributions of each nominated individual or team member and how they played critical roles in the development of the technology and/or the application of the technology to prevent, diagnose, or treat human disease
• If nominating individuals, a brief biographical paragraph of up to 300 words for each nominee highlighting background, key accomplishments, and current positions
• If nominating a team, a list of all team member names, titles, affiliations, and research areas
• If individuals or teams other than the nominees have contributed to the development of the proposed technology, a list of up to four who have made the most prominent contributions and a 100-word or less statement of why they were not included among the nominees
• If nominating individuals, a full CV (or a link to a full CV) for each nominee
• A list of up to ten article references that represent the work of the entire set of nominees and are relevant to the development or use of the proposed technology
• Names and contact information of up to six knowledgeable individuals who could provide well-informed views of the technical achievement and of those who have been nominated to receive the award

To begin a nomination, click here.
 

Eligibility for the Merkin Prize extends to all living investigators who have developed important, novel health technologies that have demonstrably improved human health in a clinical setting. Please note: Current Broad employees and Institute Members are ineligible to receive the Prize.
Click here for detailed eligibility criteria.
 

No. Self-nominations are not permitted; however, anyone may nominate an innovator for the prize.
 

To qualify for a team nomination, the nominated technology could not have been created without the specific contributions of each team member.

A nominated team may come from any field. Eligible team members include all of those who have directly contributed to the development of the nominated technology. Those in primarily administrative roles are not eligible for the prize.

Consortia, Institutions, and/or Organizations are not eligible to receive the prize.
 

Nominators are limited to two nominations per year.
 

No. However, nominators must submit the names and contact information for up to six individuals whom the committee could contact for additional information about the nominees and the nominated technology.
 

Nominations will be evaluated over during the winter & spring of 2023 by a blue ribbon panel of scientific leaders, chaired by Nobel Laureate Dr. Harold Varmus.
 

Nominations will close in January 2023. Winners will be announced in early summer and honored at a prize ceremony in fall 2023.
 

2023 marks the inaugural year of the Merkin Prize. To learn more about Dr. Richard N. Merkin, the Merkin Family Foundation, and other groundbreaking research he has supported, click here.
 

Contact Proposal Central Support directly via email at pcsupport@altum.com, or by phone at +1 800 875 2562 (Toll-free U.S. and Canada) and +1 703 964 5840 (Direct Dial International).
 

Email merkinprize@broadinstitute.org